The aging lung microenvironment awakens melanoma metastases
- PMID: 35868308
- DOI: 10.1016/j.ccell.2022.06.013
The aging lung microenvironment awakens melanoma metastases
Abstract
In a recent publication in Nature, Fane et al. establish WNT5A as a central, age-sensitive regulator of the dormancy-to-reactivation axis of melanoma. They show that aged fibroblasts in the lungs suppress WNT5A signaling induced at the primary tumor site to awaken dormant melanoma cells and promote the outgrowth of metastases.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Stromal changes in the aged lung induce an emergence from melanoma dormancy.Nature. 2022 Jun;606(7913):396-405. doi: 10.1038/s41586-022-04774-2. Epub 2022 Jun 1. Nature. 2022. PMID: 35650435 Free PMC article.
Similar articles
-
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.ACS Nano. 2018 Feb 27;12(2):1250-1261. doi: 10.1021/acsnano.7b07384. Epub 2018 Jan 31. ACS Nano. 2018. PMID: 29370526 Free PMC article.
-
Wnt5a induces and maintains prostate cancer cells dormancy in bone.J Exp Med. 2019 Feb 4;216(2):428-449. doi: 10.1084/jem.20180661. Epub 2018 Dec 28. J Exp Med. 2019. PMID: 30593464 Free PMC article.
-
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.Mol Cell. 2020 Feb 6;77(3):633-644.e5. doi: 10.1016/j.molcel.2019.11.009. Epub 2019 Dec 11. Mol Cell. 2020. PMID: 31836388 Free PMC article.
-
The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment.Cancer Metastasis Rev. 2020 Sep;39(3):933-952. doi: 10.1007/s10555-020-09878-7. Cancer Metastasis Rev. 2020. PMID: 32435939 Review.
-
Cancer treatments as paradoxical catalysts of tumor awakening in the lung.Cancer Metastasis Rev. 2024 Dec;43(4):1165-1183. doi: 10.1007/s10555-024-10196-5. Epub 2024 Jul 4. Cancer Metastasis Rev. 2024. PMID: 38963567 Free PMC article. Review.
Cited by
-
Identifying fibroblast-derived sFRP2 as a therapeutic target and engineering siRNA therapy for uterine scarring.Nat Commun. 2025 Jul 25;16(1):6850. doi: 10.1038/s41467-025-62248-1. Nat Commun. 2025. PMID: 40715133 Free PMC article.
-
A de novo dual-targeting supramolecular self-assembly peptide against pulmonary metastasis of melanoma.Theranostics. 2023 Jun 26;13(11):3844-3855. doi: 10.7150/thno.83819. eCollection 2023. Theranostics. 2023. PMID: 37441586 Free PMC article.
-
The Activity of YCA1 Metacaspase Is Regulated by Reactive Sulfane Sulfur via Persulfidation in Saccharomyces cerevisiae.Antioxidants (Basel). 2024 May 10;13(5):589. doi: 10.3390/antiox13050589. Antioxidants (Basel). 2024. PMID: 38790694 Free PMC article.
-
Chemotherapy-induced PTEN-L secretion promotes the selection of PTEN-deficient tumor cells.J Exp Clin Cancer Res. 2024 May 11;43(1):140. doi: 10.1186/s13046-024-03059-y. J Exp Clin Cancer Res. 2024. PMID: 38730468 Free PMC article.
-
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x. Mol Cancer. 2024. PMID: 39574178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical